Emerging research on the potential benefits of GLP-1swhich include semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro and Zepbound)for treating PCOS suggests Nirchi may be far from alone in finding this type of drug life-changing
In these studies, GLP-1 receptor agonist treatment consistently reduced urinary albumin-to-creatinine ratios (UACRs) by 20%40% and new-onset macroalbuminuria in people with T2D (12, 13)
External resources For researchers serious about understanding the full landscape of weight loss medications and making informed decisions about peptide-based treatments, SeekPeptides provides the most comprehensive resource available, with evidence-based guides, detailed comparison tools, and a community of thousands who have navigated these exact questions
Lodhia 2 Andrew Jenkins 2 Ahmed Elnaiem 6 Mayssan Muftah 2 Ryan Flanagan 2 Walter W
This is not a unique phenomenon to GLP-1 medications and is similar to what we observe with medications that treat other chronic conditions, like high blood pressure, asthma, or inflammatory bowel disease, Maselli says
GLP-1 testing delivers several important findings about your metabolic state